These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 15751737)
41. [Discovery of AIDS virus behind the scenes]. Kohn A Harefuah; 1991 Aug; 121(3-4):135-6. PubMed ID: 1752574 [No Abstract] [Full Text] [Related]
42. [Role of the membrane curvature factor IRSp53 in HIV-1 particle assembly and budding]. Muriaux D Med Sci (Paris); 2022 Mar; 38(3):246-248. PubMed ID: 35333159 [No Abstract] [Full Text] [Related]
43. Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain. Zhang H; Curreli F; Zhang X; Bhattacharya S; Waheed AA; Cooper A; Cowburn D; Freed EO; Debnath AK Retrovirology; 2011 May; 8():28. PubMed ID: 21539734 [TBL] [Abstract][Full Text] [Related]
44. Virtual screening based identification of novel small-molecule inhibitors targeted to the HIV-1 capsid. Curreli F; Zhang H; Zhang X; Pyatkin I; Victor Z; Altieri A; Debnath AK Bioorg Med Chem; 2011 Jan; 19(1):77-90. PubMed ID: 21168336 [TBL] [Abstract][Full Text] [Related]
45. A perspective of the dynamic structure of the nucleus explored at the single-molecule level. Dange T; Joseph A; Grünwald D Chromosome Res; 2011 Jan; 19(1):117-29. PubMed ID: 20842420 [TBL] [Abstract][Full Text] [Related]
46. Role of protein interactions in defining HIV-1 viral capsid shape and stability: a coarse-grained analysis. Krishna V; Ayton GS; Voth GA Biophys J; 2010 Jan; 98(1):18-26. PubMed ID: 20085716 [TBL] [Abstract][Full Text] [Related]
48. Solution structure of a hydrocarbon stapled peptide inhibitor in complex with monomeric C-terminal domain of HIV-1 capsid. Bhattacharya S; Zhang H; Debnath AK; Cowburn D J Biol Chem; 2008 Jun; 283(24):16274-8. PubMed ID: 18417468 [TBL] [Abstract][Full Text] [Related]
49. Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions. Loureiro J; Ploegh HL Adv Immunol; 2006; 92():225-305. PubMed ID: 17145306 [TBL] [Abstract][Full Text] [Related]
50. 3-O-(3',3'-dimethysuccinyl) betulinic acid inhibits maturation of the human immunodeficiency virus type 1 Gag precursor assembled in vitro. Sakalian M; McMurtrey CP; Deeg FJ; Maloy CW; Li F; Wild CT; Salzwedel K J Virol; 2006 Jun; 80(12):5716-22. PubMed ID: 16731910 [TBL] [Abstract][Full Text] [Related]
51. HIV-1 assembly and budding as targets for drug discovery. Li F; Wild C Curr Opin Investig Drugs; 2005 Feb; 6(2):148-54. PubMed ID: 15751737 [TBL] [Abstract][Full Text] [Related]
52. Assembly of the HIV-1 core particle. Kaplan AH AIDS Rev; 2002; 4(2):104-11. PubMed ID: 12152518 [TBL] [Abstract][Full Text] [Related]
53. Inhibition of viral assembly in murine cells by HIV-1 matrix. Hübner W; Chen BK Virology; 2006 Aug; 352(1):27-38. PubMed ID: 16750235 [TBL] [Abstract][Full Text] [Related]
54. Maturation inhibitors: a new therapeutic class targets the virus structure. Salzwedel K; Martin DE; Sakalian M AIDS Rev; 2007; 9(3):162-72. PubMed ID: 17982941 [TBL] [Abstract][Full Text] [Related]
55. Discovery of dual inhibitors targeting both HIV-1 capsid and human cyclophilin A to inhibit the assembly and uncoating of the viral capsid. Li J; Tan Z; Tang S; Hewlett I; Pang R; He M; He S; Tian B; Chen K; Yang M Bioorg Med Chem; 2009 Apr; 17(8):3177-88. PubMed ID: 19328002 [TBL] [Abstract][Full Text] [Related]